Idenix Pharmaceuticals LLC;Universita degli Studi di Cagliari
发明人:
Jean-Pierre Sommadossi,Paolo La Colla
申请号：
US16440659
公开号：
US10758557B2
申请日:
2019.06.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′；, 2′； or 3′；-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
